M Kozlowski

Summary

Affiliation: Health Canada
Country: Canada

Publications

  1. ncbi Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling
    G Pani
    Department of Medicine, University of Toronto, Ontario, Canada
    J Exp Med 181:2077-84. 1995
  2. ncbi SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain
    M Kozlowski
    Health Canada Life Sciences and the University of Ottawa, Canada
    Mol Cell Biol 18:2089-99. 1998
  3. ncbi Small molecule insulin receptor activators potentiate insulin action in insulin-resistant cells
    M Li
    University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94143-1616, USA
    Diabetes 50:2323-8. 2001
  4. ncbi Differential effect of IL-4 and IL-13 on CD44 expression in the Burkitt's lymphoma B cell line BL30/B95-8 and in Epstein-Barr virus (EBV) transformed human B cells: loss of IL-13 receptors on Burkitt's lymphoma B cells
    K Gee
    Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada
    Cell Immunol 211:131-42. 2001
  5. ncbi NK lytic-associated molecule: a novel gene selectively expressed in cells with cytolytic function
    M Kozlowski
    Department of Pathology, St Louis University School of Medicine, Veterans Administration Medical Center, MO 63106, USA
    J Immunol 163:1775-85. 1999

Collaborators

  • M Li
  • K Gee
  • V P Manchem
  • A Kumar
  • M Kryworuchko
  • F Diaz-Mitoma
  • B A Maddux
  • J F Youngren
  • B B Zhang
  • I D Goldfine
  • G Pani
  • G B Mills
  • J C Cambier
  • K A Siminovitch

Detail Information

Publications5

  1. ncbi Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling
    G Pani
    Department of Medicine, University of Toronto, Ontario, Canada
    J Exp Med 181:2077-84. 1995
    ..Together these results suggest a critical role for PTP1C in modulating BCR signaling capacity, and they indicate that the PTP1C influence on B cell signaling is likely to be realized in both resting and activated cells...
  2. ncbi SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain
    M Kozlowski
    Health Canada Life Sciences and the University of Ottawa, Canada
    Mol Cell Biol 18:2089-99. 1998
    ....
  3. ncbi Small molecule insulin receptor activators potentiate insulin action in insulin-resistant cells
    M Li
    University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94143-1616, USA
    Diabetes 50:2323-8. 2001
    ..In summary, these two classes of IR activators selectively increased IR function in a variety of insulin-resistant cell lines...
  4. ncbi Differential effect of IL-4 and IL-13 on CD44 expression in the Burkitt's lymphoma B cell line BL30/B95-8 and in Epstein-Barr virus (EBV) transformed human B cells: loss of IL-13 receptors on Burkitt's lymphoma B cells
    K Gee
    Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada
    Cell Immunol 211:131-42. 2001
    ..The inability of BL30/B95-8 cells to respond to IL-13 was attributed to the loss of expression of IL-13R subunits alpha1 and alpha2, a finding confirmed for a number of other BL cell lines examined...
  5. ncbi NK lytic-associated molecule: a novel gene selectively expressed in cells with cytolytic function
    M Kozlowski
    Department of Pathology, St Louis University School of Medicine, Veterans Administration Medical Center, MO 63106, USA
    J Immunol 163:1775-85. 1999
    ..Further study of this gene may add to our understanding of cytotoxic processes common to NK cells, CTL, and activated macrophages...